Magnetic resonance imaging in rheumatoid arthritis advances and research priorities

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Magnetic resonance imaging in rheumatoid arthritis advances and research priorities. / Østergaard, Mikkel; McQueen, FM; Bird, P; Ejbjerg, B; Lassere, MN; Peterfy, CG; O'Connor, PJ; Haavardsholm, E; Shnier, R; Genant, HK; Emery, P; Edmonds, JP; Conaghan, PG.

I: Journal of Rheumatology, Bind 32, Nr. 12, 2005, s. 2462-4.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Østergaard, M, McQueen, FM, Bird, P, Ejbjerg, B, Lassere, MN, Peterfy, CG, O'Connor, PJ, Haavardsholm, E, Shnier, R, Genant, HK, Emery, P, Edmonds, JP & Conaghan, PG 2005, 'Magnetic resonance imaging in rheumatoid arthritis advances and research priorities', Journal of Rheumatology, bind 32, nr. 12, s. 2462-4. <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16331788&query_hl=2&itool=pubmed_docsum>

APA

Østergaard, M., McQueen, FM., Bird, P., Ejbjerg, B., Lassere, MN., Peterfy, CG., O'Connor, PJ., Haavardsholm, E., Shnier, R., Genant, HK., Emery, P., Edmonds, JP., & Conaghan, PG. (2005). Magnetic resonance imaging in rheumatoid arthritis advances and research priorities. Journal of Rheumatology, 32(12), 2462-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16331788&query_hl=2&itool=pubmed_docsum

Vancouver

Østergaard M, McQueen FM, Bird P, Ejbjerg B, Lassere MN, Peterfy CG o.a. Magnetic resonance imaging in rheumatoid arthritis advances and research priorities. Journal of Rheumatology. 2005;32(12):2462-4.

Author

Østergaard, Mikkel ; McQueen, FM ; Bird, P ; Ejbjerg, B ; Lassere, MN ; Peterfy, CG ; O'Connor, PJ ; Haavardsholm, E ; Shnier, R ; Genant, HK ; Emery, P ; Edmonds, JP ; Conaghan, PG. / Magnetic resonance imaging in rheumatoid arthritis advances and research priorities. I: Journal of Rheumatology. 2005 ; Bind 32, Nr. 12. s. 2462-4.

Bibtex

@article{5a466f54abd74c9589b2cf4cc5b9b744,
title = "Magnetic resonance imaging in rheumatoid arthritis advances and research priorities",
abstract = "Magnetic resonance imaging (MRI) has now been used extensively in cross-sectional and observational studies as well as in controlled clinical trials to assess disease activity and joint damage in rheumatoid arthritis (RA). MRI measurements or scores for erosions, bone edema, and synovitis have been developed and validated by several groups. The OMERACT criteria require that outcome measures demonstrate adequate validity, discriminative power, and feasibility if they are to be useful in clinical trials. Specific performance targets for these criteria depend on the scientific, regulatory, logistical, and financial context of the study in question. We review the extent to which MRI assessments of joint erosion, bone edema, and synovitis fulfil these criteria, particularly as they relate to proof-of-concept RA clinical trials.",
author = "Mikkel {\O}stergaard and FM McQueen and P Bird and B Ejbjerg and MN Lassere and CG Peterfy and PJ O'Connor and E Haavardsholm and R Shnier and HK Genant and P Emery and JP Edmonds and PG Conaghan",
year = "2005",
language = "English",
volume = "32",
pages = "2462--4",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology Publishing Co. Ltd.",
number = "12",

}

RIS

TY - JOUR

T1 - Magnetic resonance imaging in rheumatoid arthritis advances and research priorities

AU - Østergaard, Mikkel

AU - McQueen, FM

AU - Bird, P

AU - Ejbjerg, B

AU - Lassere, MN

AU - Peterfy, CG

AU - O'Connor, PJ

AU - Haavardsholm, E

AU - Shnier, R

AU - Genant, HK

AU - Emery, P

AU - Edmonds, JP

AU - Conaghan, PG

PY - 2005

Y1 - 2005

N2 - Magnetic resonance imaging (MRI) has now been used extensively in cross-sectional and observational studies as well as in controlled clinical trials to assess disease activity and joint damage in rheumatoid arthritis (RA). MRI measurements or scores for erosions, bone edema, and synovitis have been developed and validated by several groups. The OMERACT criteria require that outcome measures demonstrate adequate validity, discriminative power, and feasibility if they are to be useful in clinical trials. Specific performance targets for these criteria depend on the scientific, regulatory, logistical, and financial context of the study in question. We review the extent to which MRI assessments of joint erosion, bone edema, and synovitis fulfil these criteria, particularly as they relate to proof-of-concept RA clinical trials.

AB - Magnetic resonance imaging (MRI) has now been used extensively in cross-sectional and observational studies as well as in controlled clinical trials to assess disease activity and joint damage in rheumatoid arthritis (RA). MRI measurements or scores for erosions, bone edema, and synovitis have been developed and validated by several groups. The OMERACT criteria require that outcome measures demonstrate adequate validity, discriminative power, and feasibility if they are to be useful in clinical trials. Specific performance targets for these criteria depend on the scientific, regulatory, logistical, and financial context of the study in question. We review the extent to which MRI assessments of joint erosion, bone edema, and synovitis fulfil these criteria, particularly as they relate to proof-of-concept RA clinical trials.

M3 - Journal article

VL - 32

SP - 2462

EP - 2464

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 12

ER -

ID: 34061782